Alzheimer's Disease Trial, By Invitation NCT07694921 Sponsor: First Affiliated Hospital of Zhejiang University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, By Invitation

NCT07694921
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are right-handed and of Han ethnicity.
  • People who have been diagnosed with Alzheimer's disease according to the standard DSM-5 diagnostic criteria.
  • People who are aged 60 or older, have completed at least primary school education, and are able to cooperate during testing.
  • People who score below 24 on the Mini-Mental State Examination (MMSE), a standard test of memory and thinking ability.
  • People who score 0.5 or 1 on the Clinical Dementia Rating (CDR) scale, which indicates mild memory or thinking difficulties.
  • People who score 20 or higher on the 24-item Hamilton Depression Scale (HAMD-24), a standard measure of depression severity.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose memory or thinking difficulties are caused by a whole-body illness, such as an underactive thyroid, vitamin B12 or folate deficiency, or HIV/AIDS.
  • People who also have a neurological condition such as epilepsy, Parkinson's disease, normal-pressure hydrocephalus, or a brain tumour.
  • People who also have a mental health condition such as schizophrenia, bipolar disorder, or a psychiatric condition caused by alcohol or drug use.
  • People who have a history of losing consciousness after a head injury, an infection inside the skull, or disease affecting the blood vessels of the brain.
  • People who score 4 or higher on the Hachinski Ischemic Scale, a tool used to assess the likelihood that strokes have contributed to cognitive decline (confirm with trial site).
  • People whose brain MRI scan shows areas of reduced blood flow in key brain regions such as the hippocampus, thalamus, basal ganglia, or angular gyrus, or multiple such areas in the deep parts of the brain.
  • People who are unable to have an MRI scan, for example due to metal implants in their body or a pacemaker.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
First Affiliated Hospital of Zhejiang University
Registry
ClinicalTrials.gov
Start date
16 June 2026
Est. completion
31 October 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Alzheimer Disease Assessment Scale-Cognitive(ADAS-Cog); The 24-item Hamilton Depression Scale (HAMD-24)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov